Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor — Dominique Schols (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor
Shared by
De Clercq Erik
KU Leuven
Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor
Article
2006
en
Authors
+2 more
DS
Dominique Schols
KL
Kristel Van Laethem
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor
Kurt Vermeire
,
Thomas W. Bell
,
Roger Le Grand
,
De Clercq Erik
,
Dominique Schols
Article
2006
The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells
Kurt Vermeire
,
Thomas W. Bell
,
S. Anugu
,
N.H. Duffy
,
Roger Le Grand
,
De Clercq Erik
,
Dominique Schols
Article
2004
A novel class of HIV inhibitors that target the cellular CD4 receptor
Kurt Vermeire
,
T.W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2004
CADA compounds: potent CD4-targeted HIV inhibitors
Kurt Vermeire
,
Thomas W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2001
CADA compounds: inhibitors of HIV and HHV-7 replication via down-modulation of CD4 receptor expression
Thomas W. Bell
,
K Dey
,
Qi Jin
,
M Samala
,
Emily Scarbrough
,
A Sodoma
,
Kurt Vermeire
,
De Clercq Erik
,
Dominique Schols
Discussion(0)
No comments yet. Be the first to comment.